Researchers say vaccine appears to 'mop up' leukemia cells Gleevec leaves behind

Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).

Read the whole article on Physorg

More from Physorg